S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

PHASE3RecruitingINTERVENTIONAL

Enrollment

1,006

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

May 1, 2027

Conditions

Gastric Cancer

Interventions

DRUG

S-1 for 9 months

S-1 for 9 months after D2 resection

DRUG

S-1 for 1 year

S-1 for 1 year after D2 resection

Trial Locations (6)

RECRUITING

Anqing Municipal Hospital, Anqing

RECRUITING

Second Affiliated Hospital, School of Medicine, Hangzhou

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

Jiangxi Provincial Cancer Hospital, Nanchang

RECRUITING

Dazhi Xu, Shanghai

RECRUITING

First Affiliated Hospital of Wannan Medical College, Wuhu

All Listed Sponsors

lead

Fudan University

OTHER

NCT03941561 - S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） | Biotech Hunter | Biotech Hunter